With the continuous improvement of the capital market interconnection mechanism, the “two-way” listing boom between A-shares and Hong Kong stocks is sweeping the market with unprecedented vigor. The Hong Kong stock biotech company Baiosetu will soon land on the Science and Technology Innovation Board, becoming another landmark event of two-way interaction between the capital markets of the two places in 2025. From Hong Kong stock companies “returning home” back to A, to A-share companies “going overseas” to going to Hong Kong, to the cross-market layout of subsidiaries spin-off and listing, the A+H listing ecosystem continues to enrich, not only opening up diversified financing channels for enterprises, but also promoting the deep integration of mainland and Hong Kong capital markets in terms of resource allocation and institutional innovation.

With the continuous improvement of the capital market interconnection mechanism, the “two-way” listing boom between A-shares and Hong Kong stocks is sweeping the market with unprecedented vigor. The Hong Kong stock biotech company Baiosetu will soon land on the Science and Technology Innovation Board, becoming another landmark event of two-way interaction between the capital markets of the two places in 2025. From Hong Kong stock companies “returning home” back to A, to A-share companies “going overseas” to going to Hong Kong, to the cross-market layout of subsidiaries spin-off and listing, the A+H listing ecosystem continues to enrich, not only opening up diversified financing channels for enterprises, but also promoting the deep integration of mainland and Hong Kong capital markets in terms of resource allocation and institutional innovation.